Maria Teresa Peracchia is the Global Head, Drug Delivery and Product Integration within Biologics Drug Product Development (BioDPD) since 1st March 2019. Maria Teresa joined Sanofi in 1999. Previously (2013-2019) she served as CMC Project Leader for Dupilumab (Dupixent®) developed in collaboration with Regeneron, where she led the CMC team through successful submission, registration and launch of Dupilumab for Atopic Dermatitis and Asthma indications. Prior to this, Maria-Teresa held several positons of increasing responsibility in the formulation and drug delivery groups within Sanofi. She has authored/ co-authored over 20 publications in the field of drug delivery and filed 8 patents.
Maria-Teresa holds a PhD in Pharmacy from the University of Parma. She was a Visiting Scientist (1992-1994) in Prof. Robert Langer’s lab at MIT, developing PEGylated polymeric nanoparticles (Science, 1994) and a post-doctoral fellow (1995-1998) with Prof. Patrick Couvreur at the University Paris-XI.